← All stocks

Faeth Therapeutics, Inc.

FTH No buying or selling
CIK 0001829802 #2705 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Parikh Anand Kiran
President and CEO
817,699
$19.80M
Peyer James
10% owner
285,284
$6.91M
−15.5%
MILLENNIUM MANAGEMENT LLC entity
10% owner
133,986
$3.25M
+21.7%
Cambrian BioPharma Inc entity
10% owner
130,142
$3.15M
−28.7%
Celebi John
PRESIDENT AND CEO
105,862
$2.56M
−5.0%
van der Horst Edward
CHIEF SCIENTIFIC OFFICER
59,794
$1.45M
−3.7%
STEPHENSON BRIAN C
Chief Financial Officer
46,688
$1.13M
Hahn Stephen M.
Director
44,763
$1.08M

No percentages here. This company's share count has moved by a factor of 20.5 over the window, from 1,261,290 to 25,840,425 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 5 Feb 2021